LeAnne T. Bloedon

7.0k total citations · 4 hit papers
51 papers, 4.4k citations indexed

About

LeAnne T. Bloedon is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, LeAnne T. Bloedon has authored 51 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 16 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Cancer Research. Recurrent topics in LeAnne T. Bloedon's work include Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (10 papers). LeAnne T. Bloedon is often cited by papers focused on Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Cancer, Lipids, and Metabolism (10 papers). LeAnne T. Bloedon collaborates with scholars based in United States, Canada and Italy. LeAnne T. Bloedon's co-authors include Daniel J. Rader, Philippe Szapary, Megan L. Wolfe, Lulu Ren Sterling, Marina Cuchel, James P. Mancuso, Margaret E. Brousseau, Andrés Digenio, Ernst J. Schaefer and Ronald W. Clark and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

LeAnne T. Bloedon

47 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

2004 574 citations Margaret E. Brousseau, Ernst J. Schaefer et al. New England Journal of Medicine profile →
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

2019 537 citations Kausik K. Ray, Harold Bays et al. New England Journal of Medicine profile →
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

2012 524 citations Marina Cuchel, Emma A. Meagher et al. The Lancet profile →
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

2019 301 citations Ulrich Laufs, Daniel Gaudet et al. Journal of the American Heart Association profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
LeAnne T. Bloedon United States	24	2.5k	1.7k	867	853	773	51	4.4k
Leiv Ose Norway	43	3.6k 1.4×	1.6k 0.9×	1.0k 1.2×	910 1.1×	866 1.1×	161	5.8k
Olivier Descamps Belgium	28	2.9k 1.2×	1.5k 0.9×	841 1.0×	1.1k 1.3×	492 0.6×	86	4.5k
Hanna Mäenpää Finland	22	2.0k 0.8×	1.7k 1.1×	825 1.0×	746 0.9×	945 1.2×	54	4.8k
Tamio Teramoto Japan	38	2.6k 1.0×	1.7k 1.0×	671 0.8×	1.5k 1.7×	878 1.1×	212	5.6k
Maria-Corina Șerban Romania	39	1.6k 0.7×	699 0.4×	418 0.5×	751 0.9×	760 1.0×	87	4.5k
Pedro Mata Spain	36	2.7k 1.1×	1.0k 0.6×	934 1.1×	830 1.0×	580 0.8×	119	4.0k
Diane L. Tribble United States	34	2.9k 1.2×	2.0k 1.2×	997 1.1×	1.0k 1.2×	1.3k 1.7×	65	7.2k
John R. Burnett Australia	36	2.5k 1.0×	1.3k 0.8×	694 0.8×	956 1.1×	1.3k 1.7×	164	4.6k
Rafael Carmena Spain	32	2.1k 0.8×	2.1k 1.3×	489 0.6×	911 1.1×	697 0.9×	154	4.6k
P. Barton Duell United States	33	2.6k 1.0×	1.0k 0.6×	505 0.6×	745 0.9×	619 0.8×	114	4.7k

Countries citing papers authored by LeAnne T. Bloedon

Since Specialization

Citations

This map shows the geographic impact of LeAnne T. Bloedon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LeAnne T. Bloedon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LeAnne T. Bloedon more than expected).

Fields of papers citing papers by LeAnne T. Bloedon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LeAnne T. Bloedon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LeAnne T. Bloedon. The network helps show where LeAnne T. Bloedon may publish in the future.

Co-authorship network of co-authors of LeAnne T. Bloedon

This figure shows the co-authorship network connecting the top 25 collaborators of LeAnne T. Bloedon. A scholar is included among the top collaborators of LeAnne T. Bloedon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LeAnne T. Bloedon. LeAnne T. Bloedon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bays, Harold, LeAnne T. Bloedon, Danielle M. Brennan, et al.. (2025). Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis. Journal of the American Heart Association. 14(4). e037898–e037898.

Nicholls, Stephen J., Kausik K. Ray, A. Michael Lincoff, et al.. (2025). Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. American Journal of Cardiovascular Drugs. 26(1). 59–70.

Mukherjee, Debabrata, Stephen J. Nicholls, Michael Li, et al.. (2025). EFFICACY AND SAFETY OF BEMPEDOIC ACID IN PATIENTS ≥75 YEARS: ANALYSIS OF CLEAR OUTCOMES. Journal of the American College of Cardiology. 85(12). 2631–2631.

Laffin, Luke J., Ashish Sarraju, A. Michael Lincoff, et al.. (2024). Impact of the COVID‐19 Pandemic on Conduct and Results of CLEAR Outcomes Trial. Clinical Cardiology. 47(8). e24328–e24328. 2 indexed citations

Laufs, Ulrich, A. Michael Lincoff, Stephen J. Nicholls, et al.. (2024). Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial. Journal of clinical lipidology. 19(2). 337–347. 5 indexed citations

Bays, Harold, LeAnne T. Bloedon, Grace Lin, et al.. (2023). Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance. Journal of clinical lipidology. 18(1). e59–e69. 21 indexed citations

Cuchel, Marina, Dirk Blom, Maurizio Averna, et al.. (2013). Abstract 16516: Sustained LDL-C Lowering and Stable Hepatic Fat Levels in Patients With Homozygous Familial Hypercholesterolemia Treated With the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide: Results of an Ongoing Long-Term Extension Study. Circulation. 11 indexed citations

Tuteja, Sony, Danielle Duffy, Richard L. Dunbar, et al.. (2013). Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(3). 227–239. 25 indexed citations

Cuchel, Marina, Emma A. Meagher, Dirk Blom, et al.. (2012). Abstract 17396: Apheresis Treatment does not Affect the Lipid-Lowering Efficacy of Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Patients with Homozygous Familial Hypercholesterolemia. Circulation. 126. 3 indexed citations

10.

Cuchel, Marina, Emma A. Meagher, Hendrik du Toit Theron, et al.. (2012). Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. The Lancet. 381(9860). 40–46. 524 indexed citations breakdown →

11.

Cuchel, Marina, Emma A. Meagher, A. David Marais, et al.. (2009). Abstract 1077: A Phase III Study of Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide (AEGR-733) in Patients With Homozygous Familial Hypercholesterolemia: Interim Results at 6 Months. Circulation. 120. 4 indexed citations

12.

Cohen, Debbie L., LeAnne T. Bloedon, John T. Farrar, et al.. (2009). Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2011(1). 546428–546428. 72 indexed citations

13.

Pellizzon, Michael, Jeffery T. Billheimer, LeAnne T. Bloedon, Philippe Szapary, & Daniel J. Rader. (2007). Flaxseed Reduces Plasma Cholesterol Levels in Hypercholesterolemic Mouse Models. Journal of the American College of Nutrition. 26(1). 66–75. 48 indexed citations

14.

Cuchel, Marina, LeAnne T. Bloedon, Philippe Szapary, et al.. (2007). Inhibition of Microsomal Triglyceride Transfer Protein in Familial Hypercholesterolemia. New England Journal of Medicine. 356(2). 148–156. 416 indexed citations

15.

Szapary, Philippe, LeAnne T. Bloedon, Frederick F. Samaha, et al.. (2005). Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome. Arteriosclerosis Thrombosis and Vascular Biology. 26(1). 182–188. 130 indexed citations

16.

Bloedon, LeAnne T. & Philippe Szapary. (2004). Flaxseed and Cardiovascular Risk. Nutrition Reviews. 62(1). 18–27. 32 indexed citations

17.

Brousseau, Margaret E., Ernst J. Schaefer, Megan L. Wolfe, et al.. (2004). Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol. New England Journal of Medicine. 350(15). 1505–1515. 574 indexed citations breakdown →

18.

Szapary, Philippe, LeAnne T. Bloedon, & Gary D. Foster. (2003). Physical activity and its effects on lipids. Current Cardiology Reports. 5(6). 488–493. 44 indexed citations

19.

Szapary, Philippe, Megan L. Wolfe, LeAnne T. Bloedon, et al.. (2003). Guggulipid for the Treatment of Hypercholesterolemia. JAMA. 290(6). 765–765. 163 indexed citations

20.

Bloedon, LeAnne T., A. Robert Jeffcoat, Wlodek Lopaczynski, et al.. (2002). Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women,,. American Journal of Clinical Nutrition. 76(5). 1126–1137. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact